Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Top Cited Papers
Open Access
- 1 December 2008
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 135 (6) , 1972-1983.e11
- https://doi.org/10.1053/j.gastro.2008.08.008
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Molecular targeted therapies in hepatocellular carcinoma†Hepatology, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Assessing the significance of chromosomal aberrations in cancer: Methodology and application to gliomaProceedings of the National Academy of Sciences, 2007
- Characterizing the cancer genome in lung adenocarcinomaNature, 2007
- Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancerOncogene, 2006
- GenePattern 2.0Nature Genetics, 2006
- Exploiting the PI3K/AKT Pathway for Cancer Drug DiscoveryNature Reviews Drug Discovery, 2005
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- GenMAPP, a new tool for viewing and analyzing microarray data on biological pathwaysNature Genetics, 2002
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001